Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Private Formulations

This article was originally published in The Tan Sheet

Executive Summary

Private Formulations: Halts production of Medicine Shoppe Gas Relief Tab 24X100 and Simethicone 80 after 750 cases of the product were seized by the St. Louis District Attorney's office in November. FDA requested the seizure after it found that Edison, N.J.-based Private Formulations, the product manufacturer, failed to meet good manufacturing practices. Private Formulations was charged with failure to ensure proper validation of the product, failure to use appropriate testing procedures, failure to validate its test methods, and failure to adhere to an adequate stability program. Medicine Shoppe voluntarily withheld shipment of the product in mid-September upon FDA's request. The pills, priced at more than $28,500, were seized later at a public warehouse used by Medicine Shoppe...

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts